Transgene and Beckman Coulter sign companion diagnostic agreement
This article was originally published in Scrip
Executive Summary
Transgene and Beckham Coulter have signed an agreement that will see the latter develop a companion diagnostic test to help select which patients will benefit from Transgene's TG4010, which is in development for treating advanced non small-cell lung cancer in combination with first line therapy.